Compare · HSIC vs MCK
HSIC vs MCK
Side-by-side comparison of Henry Schein Inc. (HSIC) and McKesson Corporation (MCK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both companies sit in the Health Care sector. HSIC focuses on Medical Specialities, while MCK focuses on Other Pharmaceuticals.
- MCK is the larger of the two at $99.43B, about 10.1x HSIC ($9.85B).
- Over the past year, HSIC is up 23.4% and MCK is up 16.1% - HSIC leads by 7.3 points.
- MCK has been more active in the news (12 items in the past 4 weeks vs 3 for HSIC).
- Both have 25 recent analyst ratings on file.
- Company
- Henry Schein Inc.
- McKesson Corporation
- Price
- $86.48+0.89%
- $824.79-3.67%
- Market cap
- $9.85B
- $99.43B
- 1M return
- +0.05%
- +4.90%
- 1Y return
- +23.37%
- +16.07%
- Industry
- Medical Specialities
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NYSE
- IPO
- 1995
- News (4w)
- 3
- 12
- Recent ratings
- 25
- 25
Henry Schein Inc.
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
McKesson Corporation
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Latest HSIC
- Henry Schein Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Henry Schein Announces Leadership Transitions
- Henry Schein to Webcast Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 a.m. ET
- BMO Capital Markets initiated coverage on Henry Schein with a new price target
- GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide
- SEC Form 11-K filed by Henry Schein Inc.
- Director Daniel William K was granted 2,215 shares, increasing direct ownership by 41% to 7,641 units (SEC Form 4)
- Henry Schein upgraded by BTIG Research with a new price target
- SEC Form SD filed by Henry Schein Inc.
- New insider Murphy Kelly Ann claimed ownership of 34,812 shares (SEC Form 3)
Latest MCK
- McKesson Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 4 filed by Director Hinton James H.
- SEC Form 4 filed by Director Doughtie Lynne M
- Director Wilson-Thompson Kathleen was granted 277 shares, increasing direct ownership by 92% to 578 units (SEC Form 4)
- SEC Form 4 filed by Director Dunbar Webster Roy
- Director Caruso Dominic J was granted 277 shares, increasing direct ownership by 43% to 927 units (SEC Form 4)
- SEC Form 4 filed by Director Gerberding Julie L.
- SEC Form 4 filed by Director Lerman Bradley E
- Director Martinez Maria was granted 277 shares, increasing direct ownership by 92% to 578 units (SEC Form 4)
- SEC Form 4 filed by Director Ozan Kevin M